cardiac-surgery
(6)
Edwards Lifesciences and the art of thinking smaller
An engineer wanted to build an artificial heart. A surgeon suggested starting with a valve. Nearly seven decades later, Edwards is still finding room to grow by narrowing its focus.
Renibus Therapeutics and the art of the second chance
A kidney-drug acquisition cost $250,000 upfront. A cardiac-surgery trial missed its target. Renibus now has to show which promising ideas deserve another experiment.
Spectrum Medical wants to connect every beat of heart surgery
Pumps, disposable circuits and patient records all meet in Spectrum Medical’s Quantum range. Its expansion shows the appeal of joining them together - and the scrutiny that comes with supplying life-support technology.
CardioRenal Systems, Inc.
CardioRenal Systems is a Milford, Massachusetts medical device company developing RenalPro (marketed as RenalGuard outside the US), an automated fluid-management system that prevents acute kidney injury in high-risk hospital settings. By monitoring urine output in real time and matching IV hydration in milliliter increments, the system keeps patients balanced during cardiac surgery, catheter procedures, and ICU care. RenalPro holds FDA Breakthrough Device Designation and a CE Mark, and in a 220-patient randomized UK trial cut AKI by 52% versus standard care.
Ilya Budik
Ilya Budik is the CEO of CardioRenal Systems, a Milford, Massachusetts medical device company behind the RenalPro System (sold as RenalGuard outside the U.S.), a technology built to prevent acute kidney injury in cardiac surgery, interventional cardiology, and ICU patients. A medtech executive with roughly a decade of experience across strategy, finance, and business development, he has steered the company through FDA Breakthrough Device Designation, CE Mark approval abroad, and an FDA IDE approval clearing the way for a U.S. pivotal trial. He previously led the neurodiagnostics company NeuroQuest and worked in innovation strategy and healthcare finance.
Sam Weinstein
Sam Weinstein is a pediatric cardiac surgeon turned healthcare executive who runs SpecialtyCare, the Brentwood, Tennessee company that supplies the specialized clinical teams - perfusionists, neuromonitoring technologists, surgical assistants and sterile-processing staff - working inside more than 1,200 hospital operating rooms across 45 states. After 16 years operating on children's hearts in New York and leading more than 30 surgical mission trips to Latin America, he joined SpecialtyCare as Chief Medical Officer in 2015, became President of Operations in 2016, and has been CEO since 2017. His pitch is simple: take the largest operative procedural database in the business and use it to make surgery safer and cheaper, one case at a time.